162 related articles for article (PubMed ID: 12516194)
1. [Antibacterial therapy of pneumococcal infections caused by drug resistant microorganisms].
Sidorenko SV
Antibiot Khimioter; 2002; 47(7):31-7. PubMed ID: 12516194
[No Abstract] [Full Text] [Related]
2. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
Appelbaum PC
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence and treatment for antibiotic-resistant bacteria in respiratory infection].
Watanuki Y
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():502-7. PubMed ID: 17455671
[No Abstract] [Full Text] [Related]
4. [A new antibiotic against respiratory tract infections. More power against pneumococci].
MMW Fortschr Med; 2001 Nov; 143(44):59. PubMed ID: 11732406
[No Abstract] [Full Text] [Related]
5. What is the relevance of antimicrobial resistance on the outcome of community-acquired pneumonia caused by Streptococcus pneumoniae? (should macrolide monotherapy be used for mild pneumonia?).
Low DE
Infect Dis Clin North Am; 2013 Mar; 27(1):87-97. PubMed ID: 23398867
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of streptococcus pneumoniae to fluoroquinolones and macrolides in upper respiratory tract infections.
Mykhalko YO; Duhovych TV; Kish PP
Wiad Lek; 2017; 70(2):224-226. PubMed ID: 28511165
[TBL] [Abstract][Full Text] [Related]
7. The clinical impact of macrolide resistance in pneumococcal respiratory infections.
Garau J
Int J Antimicrob Agents; 2001; 18 Suppl 1():S33-8. PubMed ID: 11574193
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States.
Doern GV
Clin Infect Dis; 2001 Sep; 33 Suppl 3():S187-92. PubMed ID: 11524718
[TBL] [Abstract][Full Text] [Related]
9. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
Fuller JD; Low DE
Clin Infect Dis; 2005 Jul; 41(1):118-21. PubMed ID: 15937772
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of antibiotic resistance in respiratory tract infections.
Klugman KP
Int J Antimicrob Agents; 2007 Feb; 29 Suppl 1():S6-10. PubMed ID: 17307654
[TBL] [Abstract][Full Text] [Related]
11. Penicillin-resistant Streptococcus pneumoniae: selection by both beta-lactam and non-beta-lactam antibiotics.
Goldstein FW
J Antimicrob Chemother; 1999 Aug; 44(2):141-4. PubMed ID: 10473219
[No Abstract] [Full Text] [Related]
12. [Pneumococcal infections: penicillin resistance and therapeutic implications].
Kamoun A; Ben Hassen A; Mahjoubi F; Ben Redjeb S
Tunis Med; 1995 Feb; 73(2):119-23. PubMed ID: 9506153
[No Abstract] [Full Text] [Related]
13. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship of a novel class of 15-membered macrolide antibiotics known as '11a-azalides'.
Sugimoto T; Tanikawa T; Suzuki K; Yamasaki Y
Bioorg Med Chem; 2012 Oct; 20(19):5787-801. PubMed ID: 22925450
[TBL] [Abstract][Full Text] [Related]
15. Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides.
Cornick JE; Bentley SD
Microbes Infect; 2012 Jul; 14(7-8):573-83. PubMed ID: 22342898
[TBL] [Abstract][Full Text] [Related]
16. The in vivo-in vitro paradox in pneumococcal respiratory tract infections.
Bishai W
J Antimicrob Chemother; 2002 Mar; 49(3):433-6. PubMed ID: 11864942
[No Abstract] [Full Text] [Related]
17. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
Brauers J; Ewig S; Kresken M
Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly beta-lactam-resistant Streptococcus pneumoniae.
Rodríguez-Cerrato V; García P; Huelves L; García E; Del Prado G; Gracia M; Ponte C; López R; Soriano F
Antimicrob Agents Chemother; 2007 Sep; 51(9):3371-3. PubMed ID: 17576844
[TBL] [Abstract][Full Text] [Related]
19. [The microbiologist's point of view].
Gutmann L
Presse Med; 2002 Nov; 31(37 Pt 2):S4-5. PubMed ID: 12489324
[No Abstract] [Full Text] [Related]
20. Respiratory tract infection: epidemiology and surveillance.
Jacobs MR
J Chemother; 1997 May; 9 Suppl 3():10-7. PubMed ID: 9248976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
